Lipid-lowering therapy and the risk of dementia: lessons learned from two decades of controversy.

Gebhard, Catherine; Corpataux, Noé; Gräni, Christoph; Haider, Ahmed

Gebhard, Catherine; Corpataux, Noé; Gräni, Christoph; Haider, Ahmed.

Afiliación

Gebhard C; Department of Nuclear Medicine, University Hospital Zurich , Rämistrasse 100, 8091 Zurich, Switzerland.
Corpataux N; Center for Molecular Cardiology, University of Zurich, Wagistrasse 12, 8952 Schlieren, Switzerland.
Gräni C; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.
Haider A; Department of Cardiology, Inselspital, Bern University Hospital, University of Bern, Freiburgstrasse 18, 3010 Bern, Switzerland.

Eur Heart J ; 44(21): 1855-1857, 2023 06 01.

Article en En | MEDLINE | ID: mdl-36896631

Asunto(s)

Demencia; Inhibidores de Hidroximetilglutaril-CoA Reductasas; Humanos; Inhibidores de Hidroximetilglutaril-CoA Reductasas/efectos adversos; Lípidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inhibidores de Hidroximetilglutaril-CoA Reductasas / Demencia Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: Eur Heart J Año: 2023 Tipo del documento: Article País de afiliación: Suiza

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google